BioRestorative Therapies, Inc. (BRTX)
2.68
-0.08
(-2.90%)
USD |
NASDAQ |
Sep 11, 16:00
2.68
0.00 (0.00%)
After-Hours: 17:26
BioRestorative Therapies Gross Profit (TTM) : 0.119M for March 31, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.119M |
| December 31, 2025 | 0.1259M |
| September 30, 2025 | 0.1503M |
| June 30, 2025 | 0.3688M |
| March 31, 2025 | 0.1619M |
| December 31, 2024 | 0.1839M |
| September 30, 2024 | 0.1709M |
| June 30, 2024 | -0.0077M |
| March 31, 2024 | -0.0196M |
| December 31, 2023 | -0.0199M |
| September 30, 2023 | -0.0977M |
| June 30, 2023 | -0.1175M |
| March 31, 2023 | -0.1299M |
| December 31, 2022 | -0.1609M |
| September 30, 2022 | -0.1052M |
| June 30, 2022 | -0.074M |
| March 31, 2022 | -0.0846M |
| December 31, 2021 | -0.0456M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | -0.0416M |
| September 30, 2018 | -0.0677M |
| June 30, 2018 | -0.1174M |
| March 31, 2018 | -0.1626M |
| December 31, 2017 | -0.1783M |
| September 30, 2017 | -0.2118M |
| June 30, 2017 | -0.2227M |
| March 31, 2017 | -0.2262M |
| December 31, 2016 | -0.2222M |
| September 30, 2016 | -0.086M |
| June 30, 2016 | -0.0415M |
| March 31, 2016 | 0.0315M |
| December 31, 2015 | 0.1536M |
| September 30, 2015 | 0.0288M |
| June 30, 2015 | 0.1149M |
| March 31, 2015 | 0.1995M |
| December 31, 2014 | 0.1055M |
| September 30, 2014 | 0.1281M |
| June 30, 2014 | 0.0322M |
| March 31, 2014 | -0.1028M |
| December 31, 2013 | -0.1033M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Myriad Genetics, Inc. | 525.10M |
| CareDx, Inc. | 321.18M |
| Natera, Inc. | 1.753B |
| Exagen, Inc. | 41.70M |
| Sera Prognostics, Inc. | -0.86M |